Detalhe da pesquisa
1.
Immunogenicity and Safety of a 3-Dose Regimen of a SARS-CoV-2 Inactivated Vaccine in Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.
J Infect Dis
; 225(10): 1701-1709, 2022 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34958382
2.
Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine KCONVAC in Chinese Children: Randomized, Double-blind, Placebo-controlled Phase 1 and 2 Trials.
Pediatr Infect Dis J
; 42(12): 1136-1142, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37967148
3.
A phase 3 clinical trial of MINHAI PCV13 in Chinese children aged from 7 months to 5 years old.
Vaccine
; 39(47): 6947-6955, 2021 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34706841
4.
Immunogenicity and safety of a severe acute respiratory syndrome coronavirus 2 inactivated vaccine in healthy adults: randomized, double-blind, and placebo-controlled phase 1 and phase 2 clinical trials.
Chin Med J (Engl)
; 134(11): 1289-1298, 2021 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33928916